Valentina Ancarani

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - / Italy

Others

AD Scientific Index ID: 5046200

Registration, Add Profile,
Premium Membership

Print Your Certificate

Valentina Ancarani's MOST POPULAR ARTICLES

1-) Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients L Ridolfi, M Petrini, AM Granato, G Gentilcore, E Simeone, PA Ascierto, ... Journal of translational medicine 11, 1-10, 2013 732013

2-) Unexpected high response rate to traditional therapy after dendritic cell-based vaccine in advanced melanoma: update of clinical outcome and subgroup analysis L Ridolfi, M Petrini, L Fiammenghi, AM Granato, V Ancarani, E Pancisi, ... Journal of Immunology Research 2010, 2010 592010

3-) Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome L Ridolfi, M Petrini, L Fiammenghi, AM Granato, V Ancarani, E Pancisi, ... Melanoma research 21 (6), 524-529, 2011 412011

4-) Dendritic cell vaccination in metastatic melanoma turns “non-T cell inflamed” into “T-cell inflamed” tumorsJ Bulgarelli, M Tazzari, AM Granato, L Ridolfi, S Maiocchi, F De Rosa, ...Frontiers in immunology 10, 2353, 2019402019

5-) Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-α in …F de Rosa, L Ridolfi, R Ridolfi, G Gentili, L Valmorri, O Nanni, M Petrini, ...Journal of Translational Medicine 12, 1-12, 2014352014

ARTICLES

Add your articles